Open AccessThe discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent
Author(s) -
Devyani Deshpande,
Shashikant Srivastava,
Moti Chapagain,
Pooi S Lee,
Kayle Cirrincione,
Jotam G. Pasipanodya,
Tawanda Gumbo
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx306
Subject(s) - ceftazidime/avibactam , avibactam , ceftazidime , medicine , microbiology and biotechnology , extracellular , pharmacokinetics , antibacterial agent , pharmacology , chemistry , biology , antibiotics , pseudomonas aeruginosa , bacteria , biochemistry , genetics
To determine if ceftaroline and ceftazidime combined with avibactam are efficacious against pulmonary Mycobacterium avium complex (MAC) disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom